Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study.
Application of a WeChat-based mini-app as a patient reminder in Helicobacter pylori eradication: a prospective multi-center randomized controlled study.
复制标题
DOI:
10.1186/s12876-022-02614-1
复制
发表时间:
2022-12-16
影响因子:
2.4
通讯作者:
Li, Lan
中科院分区:
文献类型:
--
作者:
Sun, Kefang;Chen, Yishu;Wang, Zhenzhen;Liu, Yi;Pan, Yue;Mao, Xinli;Xu, Lei;Jin, Chaohui;Chen, Ming;Yu, Chaohui;Li, Lan
To improve the eradication rate of H. pylori, researchers have investigated the role of WeChat-based mini-app as an electronic reminding system in H. pylori treatment. Subjects from three medical centers were divided into two groups. Patients in the daily mini-app-based notification system group received daily notifications via the WeChat mini-app. Patients in the control group received one-time verbal education on the first clinical visit. Both groups received a 14-day quadruple therapy to eradicate H. pylori infection. Eradication rate, compliance, adverse events and satisfaction were evaluated. Both intention-to-treat (ITT) and per-protocol (PP) analyses were conducted. The eradication rate in the daily mini-app-based notification system group was slightly higher compared with the control group (ITT analysis: 76.70% vs. 70.73%, p = 0.312; PP analysis: 85.87% vs. 82.86%, p = 0.562). The compliance was significantly higher in the daily mini-app-based notification system group (ITT analysis: 85.52% vs. 70.48%, p = 0.028; PP analysis: 92.39% vs. 81.90%, p = 0.030). The adverse event rates were similar between the two groups (PP analysis: 36.96% vs. 40.95%, p = 0.566). No significant difference in eradication rate was seen in each subgroup analysis by age, place of residence, grade of education, or endoscopic findings. The study showed that daily mini-app-based notification improved patient compliance but not H. pylori eradication rate. Trial registration The research was registered in the Chinese Clinical Trial Registry (ChiCTR2000031011, 21/03/2020). The online version contains supplementary material available at 10.1186/s12876-022-02614-1.
登录
查看更多内容
影响因子:
29.4
作者:
Savoldi A;Carrara E;Graham DY;Conti M;Tacconelli E
通讯作者:
Tacconelli E
影响因子:
4.4
作者:
Liu, Wen Zhong;Xie, Yong;Lu, Nong Hua
通讯作者:
Lu, Nong Hua
影响因子:
24.5
作者:
Zhang, Wei;Chen, Qi;Lu, Hong
通讯作者:
Lu, Hong
影响因子:
5.5
作者:
Sutton P;Boag JM
通讯作者:
Boag JM
影响因子:
4.4
作者:
Luo, Miaomiao;Hao, Yu;Chen, Weigang
通讯作者:
Chen, Weigang